Jakarta, August 11th, 2022 – PT Kalbe Farma Tbk or Kalbe introduced Negeri Jahe Merah designed by Business Unit Bintang Toedjoe Inovasi Natural or BINA, a B2B division of Bintang Toedjoe focusing on natural ingredients in order to support the sustainability and availability of the best red gingers.

Jakarta, August 9th, 2022 – PT Kalbe Farma Tbk or Kalbe introduced Negeri Jahe Merah designed by Business Unit Bintang Toedjoe Inovasi Natural or BINA, a B2B division of Bintang Toedjoe focusing on natural ingredients in order to support the sustainability and availability of the best red gingers.

Jakarta, August 8th, 2022.   PT Kalbe Farma Tbk  (“Kalbe”), through a subsidiary of PT Enseval Putera Megatrading Tbk (“Enseval”) called PT Mostrans Global Digilog (“Mostrans”), has signed a Memorandum of Understanding (MoU) with PT Samudera Indonesia Tbk (“Samudera”) in order to develop a digital innovation in the logistic sector. The MoU instructs Samudera to invest 20% of its ownership to Mostrans. 

Jakarta, August 6th, 2022.  PT Kalbe Farma Tbk (“Kalbe”) through One Onco has conducted the 2022 Cancer Community Festival (CCF), which featured several cancer communities and support systems of cancer patients to the public, at August 6th and 7th of 2022 in Mosaic Walk of Kota Kasablanka Mall in Jakarta. The festival was intended to introduce the visions, missions, and programs of each cancer community and support system around Indonesia, as well as educating the society on how to deal with cancer patients.

Jakarta, July 29, 2022 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced that net sales reached Rp 13,875 billion in first semester 2022, growing by 12.2% compared to first semester 2021. Meanwhile, net income reached Rp 1,637 billion in first semester 2022, growing by 9.3% compared to Rp 1.497 billion in first semester 2021.